img

Global Oral Sustained and Controlled Release Formulations Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Sustained and Controlled Release Formulations Market Insights, Forecast to 2034

Global Oral Sustained and Controlled Release Formulations market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Oral Sustained and Controlled Release Formulations industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Oral Sustained and Controlled Release Formulations key manufacturers include Humanwell Healthcare Co.,Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Qilu Pharmaceutical Co Ltd, Shanghai Pharmaceuticals Holding Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., PKU HealthCare Corp.,Ltd., Overseas Pharmaceuticals, Ltd. and Novast Laboratories (China), LTD., etc. Humanwell Healthcare Co.,Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Oral Sustained and Controlled Release Formulations were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Oral Sustained and Controlled Release Formulations market and estimated to attract more attentions from industry insiders and investors.
Oral Sustained and Controlled Release Formulations can be divided into Skeleton Type, Membrane Controlled Type and Osmotic Pump Type,, etc. Skeleton Type is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Oral Sustained and Controlled Release Formulations is widely used in various fields, such as Cardiovascular System Drugs, Nervous System Drugs, Digestive System and Metabolism and Other, etc. Cardiovascular System Drugs provides greatest supports to the Oral Sustained and Controlled Release Formulations industry development. In 2022, global % sales of Oral Sustained and Controlled Release Formulations went into Cardiovascular System Drugs filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Oral Sustained and Controlled Release Formulations market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral Sustained and Controlled Release Formulations market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Humanwell Healthcare Co.,Ltd.
Nanjing Yiheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
Qilu Pharmaceutical Co Ltd
Shanghai Pharmaceuticals Holding Co.,Ltd.
Yangtze River Pharmaceutical (Group) Co., Ltd.
PKU HealthCare Corp.,Ltd.
Overseas Pharmaceuticals, Ltd.
Novast Laboratories (China), LTD.
Catalent
AstraZeneca Plc
Oakwood Labs
Ascendia Pharma
Colorcon
Pfizer Inc.
Mylan
Sandoz
Segment by Type
Skeleton Type
Membrane Controlled Type
Osmotic Pump Type

Segment by Application


Cardiovascular System Drugs
Nervous System Drugs
Digestive System and Metabolism
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Oral Sustained and Controlled Release Formulations plant distribution, commercial date of Oral Sustained and Controlled Release Formulations, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Oral Sustained and Controlled Release Formulations introduction, etc. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Oral Sustained and Controlled Release Formulations
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Oral Sustained and Controlled Release Formulations Product Introduction
1.2 Market by Type
1.2.1 Global Oral Sustained and Controlled Release Formulations Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Skeleton Type
1.2.3 Membrane Controlled Type
1.2.4 Osmotic Pump Type
1.3 Market by Application
1.3.1 Global Oral Sustained and Controlled Release Formulations Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cardiovascular System Drugs
1.3.3 Nervous System Drugs
1.3.4 Digestive System and Metabolism
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oral Sustained and Controlled Release Formulations Sales Estimates and Forecasts 2018-2029
2.2 Global Oral Sustained and Controlled Release Formulations Revenue by Region
2.2.1 Global Oral Sustained and Controlled Release Formulations Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Oral Sustained and Controlled Release Formulations Revenue by Region (2018-2024)
2.2.3 Global Oral Sustained and Controlled Release Formulations Revenue by Region (2024-2029)
2.2.4 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2018-2029)
2.3 Global Oral Sustained and Controlled Release Formulations Sales Estimates and Forecasts 2018-2029
2.4 Global Oral Sustained and Controlled Release Formulations Sales by Region
2.4.1 Global Oral Sustained and Controlled Release Formulations Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024)
2.4.3 Global Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029)
2.4.4 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Oral Sustained and Controlled Release Formulations Sales by Manufacturers
3.1.1 Global Oral Sustained and Controlled Release Formulations Sales by Manufacturers (2018-2024)
3.1.2 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Sustained and Controlled Release Formulations in 2022
3.2 Global Oral Sustained and Controlled Release Formulations Revenue by Manufacturers
3.2.1 Global Oral Sustained and Controlled Release Formulations Revenue by Manufacturers (2018-2024)
3.2.2 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oral Sustained and Controlled Release Formulations Revenue in 2022
3.3 Global Key Players of Oral Sustained and Controlled Release Formulations, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Oral Sustained and Controlled Release Formulations Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oral Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Product Offered and Application
3.8 Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Sustained and Controlled Release Formulations Sales by Type
4.1.1 Global Oral Sustained and Controlled Release Formulations Historical Sales by Type (2018-2024)
4.1.2 Global Oral Sustained and Controlled Release Formulations Forecasted Sales by Type (2024-2029)
4.1.3 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
4.2 Global Oral Sustained and Controlled Release Formulations Revenue by Type
4.2.1 Global Oral Sustained and Controlled Release Formulations Historical Revenue by Type (2018-2024)
4.2.2 Global Oral Sustained and Controlled Release Formulations Forecasted Revenue by Type (2024-2029)
4.2.3 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
4.3 Global Oral Sustained and Controlled Release Formulations Price by Type
4.3.1 Global Oral Sustained and Controlled Release Formulations Price by Type (2018-2024)
4.3.2 Global Oral Sustained and Controlled Release Formulations Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Oral Sustained and Controlled Release Formulations Sales by Application
5.1.1 Global Oral Sustained and Controlled Release Formulations Historical Sales by Application (2018-2024)
5.1.2 Global Oral Sustained and Controlled Release Formulations Forecasted Sales by Application (2024-2029)
5.1.3 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
5.2 Global Oral Sustained and Controlled Release Formulations Revenue by Application
5.2.1 Global Oral Sustained and Controlled Release Formulations Historical Revenue by Application (2018-2024)
5.2.2 Global Oral Sustained and Controlled Release Formulations Forecasted Revenue by Application (2024-2029)
5.2.3 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2029)
5.3 Global Oral Sustained and Controlled Release Formulations Price by Application
5.3.1 Global Oral Sustained and Controlled Release Formulations Price by Application (2018-2024)
5.3.2 Global Oral Sustained and Controlled Release Formulations Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Oral Sustained and Controlled Release Formulations Market Size by Type
6.1.1 US & Canada Oral Sustained and Controlled Release Formulations Sales by Type (2018-2029)
6.1.2 US & Canada Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2029)
6.2 US & Canada Oral Sustained and Controlled Release Formulations Market Size by Application
6.2.1 US & Canada Oral Sustained and Controlled Release Formulations Sales by Application (2018-2029)
6.2.2 US & Canada Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2029)
6.3 US & Canada Oral Sustained and Controlled Release Formulations Market Size by Country
6.3.1 US & Canada Oral Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Oral Sustained and Controlled Release Formulations Sales by Country (2018-2029)
6.3.3 US & Canada Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Oral Sustained and Controlled Release Formulations Market Size by Type
7.1.1 Europe Oral Sustained and Controlled Release Formulations Sales by Type (2018-2029)
7.1.2 Europe Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2029)
7.2 Europe Oral Sustained and Controlled Release Formulations Market Size by Application
7.2.1 Europe Oral Sustained and Controlled Release Formulations Sales by Application (2018-2029)
7.2.2 Europe Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2029)
7.3 Europe Oral Sustained and Controlled Release Formulations Market Size by Country
7.3.1 Europe Oral Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Oral Sustained and Controlled Release Formulations Sales by Country (2018-2029)
7.3.3 Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Oral Sustained and Controlled Release Formulations Market Size
8.1.1 China Oral Sustained and Controlled Release Formulations Sales (2018-2029)
8.1.2 China Oral Sustained and Controlled Release Formulations Revenue (2018-2029)
8.2 China Oral Sustained and Controlled Release Formulations Market Size by Application
8.2.1 China Oral Sustained and Controlled Release Formulations Sales by Application (2018-2029)
8.2.2 China Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oral Sustained and Controlled Release Formulations Market Size by Type
9.1.1 Asia Oral Sustained and Controlled Release Formulations Sales by Type (2018-2029)
9.1.2 Asia Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2029)
9.2 Asia Oral Sustained and Controlled Release Formulations Market Size by Application
9.2.1 Asia Oral Sustained and Controlled Release Formulations Sales by Application (2018-2029)
9.2.2 Asia Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2029)
9.3 Asia Oral Sustained and Controlled Release Formulations Sales by Region
9.3.1 Asia Oral Sustained and Controlled Release Formulations Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Oral Sustained and Controlled Release Formulations Revenue by Region (2018-2029)
9.3.3 Asia Oral Sustained and Controlled Release Formulations Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Market Size by Type
10.1.1 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Market Size by Application
10.2.1 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Country
10.3.1 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Humanwell Healthcare Co.,Ltd.
11.1.1 Humanwell Healthcare Co.,Ltd. Company Information
11.1.2 Humanwell Healthcare Co.,Ltd. Overview
11.1.3 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Humanwell Healthcare Co.,Ltd. Recent Developments
11.2 Nanjing Yiheng Pharmaceutical Co., Ltd.
11.2.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
11.2.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Overview
11.2.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Developments
11.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
11.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
11.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Overview
11.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments
11.4 Qilu Pharmaceutical Co Ltd
11.4.1 Qilu Pharmaceutical Co Ltd Company Information
11.4.2 Qilu Pharmaceutical Co Ltd Overview
11.4.3 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Qilu Pharmaceutical Co Ltd Recent Developments
11.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
11.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
11.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Overview
11.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Developments
11.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
11.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
11.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Overview
11.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments
11.7 PKU HealthCare Corp.,Ltd.
11.7.1 PKU HealthCare Corp.,Ltd. Company Information
11.7.2 PKU HealthCare Corp.,Ltd. Overview
11.7.3 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PKU HealthCare Corp.,Ltd. Recent Developments
11.8 Overseas Pharmaceuticals, Ltd.
11.8.1 Overseas Pharmaceuticals, Ltd. Company Information
11.8.2 Overseas Pharmaceuticals, Ltd. Overview
11.8.3 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Overseas Pharmaceuticals, Ltd. Recent Developments
11.9 Novast Laboratories (China), LTD.
11.9.1 Novast Laboratories (China), LTD. Company Information
11.9.2 Novast Laboratories (China), LTD. Overview
11.9.3 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novast Laboratories (China), LTD. Recent Developments
11.10 Catalent
11.10.1 Catalent Company Information
11.10.2 Catalent Overview
11.10.3 Catalent Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Catalent Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Catalent Recent Developments
11.11 AstraZeneca Plc
11.11.1 AstraZeneca Plc Company Information
11.11.2 AstraZeneca Plc Overview
11.11.3 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Plc Recent Developments
11.12 Oakwood Labs
11.12.1 Oakwood Labs Company Information
11.12.2 Oakwood Labs Overview
11.12.3 Oakwood Labs Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Oakwood Labs Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Oakwood Labs Recent Developments
11.13 Ascendia Pharma
11.13.1 Ascendia Pharma Company Information
11.13.2 Ascendia Pharma Overview
11.13.3 Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Ascendia Pharma Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ascendia Pharma Recent Developments
11.14 Colorcon
11.14.1 Colorcon Company Information
11.14.2 Colorcon Overview
11.14.3 Colorcon Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Colorcon Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Colorcon Recent Developments
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Information
11.15.2 Pfizer Inc. Overview
11.15.3 Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Pfizer Inc. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pfizer Inc. Recent Developments
11.16 Mylan
11.16.1 Mylan Company Information
11.16.2 Mylan Overview
11.16.3 Mylan Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Mylan Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Mylan Recent Developments
11.17 Sandoz
11.17.1 Sandoz Company Information
11.17.2 Sandoz Overview
11.17.3 Sandoz Oral Sustained and Controlled Release Formulations Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Sandoz Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Sandoz Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Sustained and Controlled Release Formulations Industry Chain Analysis
12.2 Oral Sustained and Controlled Release Formulations Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Sustained and Controlled Release Formulations Production Mode & Process
12.4 Oral Sustained and Controlled Release Formulations Sales and Marketing
12.4.1 Oral Sustained and Controlled Release Formulations Sales Channels
12.4.2 Oral Sustained and Controlled Release Formulations Distributors
12.5 Oral Sustained and Controlled Release Formulations Customers
13 Market Dynamics
13.1 Oral Sustained and Controlled Release Formulations Industry Trends
13.2 Oral Sustained and Controlled Release Formulations Market Drivers
13.3 Oral Sustained and Controlled Release Formulations Market Challenges
13.4 Oral Sustained and Controlled Release Formulations Market Restraints
14 Key Findings in The Global Oral Sustained and Controlled Release Formulations Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oral Sustained and Controlled Release Formulations Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Skeleton Type
Table 3. Major Manufacturers of Membrane Controlled Type
Table 4. Major Manufacturers of Osmotic Pump Type
Table 5. Global Oral Sustained and Controlled Release Formulations Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Oral Sustained and Controlled Release Formulations Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Oral Sustained and Controlled Release Formulations Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Oral Sustained and Controlled Release Formulations Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2018-2024)
Table 10. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2024-2029)
Table 11. Global Oral Sustained and Controlled Release Formulations Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 13. Global Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 14. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2018-2024)
Table 15. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2024-2029)
Table 16. Global Oral Sustained and Controlled Release Formulations Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Oral Sustained and Controlled Release Formulations Sales Share by Manufacturers (2018-2024)
Table 18. Global Oral Sustained and Controlled Release Formulations Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Oral Sustained and Controlled Release Formulations Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Oral Sustained and Controlled Release Formulations, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Oral Sustained and Controlled Release Formulations Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Oral Sustained and Controlled Release Formulations Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Oral Sustained and Controlled Release Formulations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Sustained and Controlled Release Formulations as of 2022)
Table 24. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Product Offered and Application
Table 26. Global Key Manufacturers of Oral Sustained and Controlled Release Formulations, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 29. Global Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (K Units)
Table 30. Global Oral Sustained and Controlled Release Formulations Sales Share by Type (2018-2024)
Table 31. Global Oral Sustained and Controlled Release Formulations Sales Share by Type (2024-2029)
Table 32. Global Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Oral Sustained and Controlled Release Formulations Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Oral Sustained and Controlled Release Formulations Revenue Share by Type (2018-2024)
Table 35. Global Oral Sustained and Controlled Release Formulations Revenue Share by Type (2024-2029)
Table 36. Oral Sustained and Controlled Release Formulations Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Oral Sustained and Controlled Release Formulations Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (K Units)
Table 39. Global Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (K Units)
Table 40. Global Oral Sustained and Controlled Release Formulations Sales Share by Application (2018-2024)
Table 41. Global Oral Sustained and Controlled Release Formulations Sales Share by Application (2024-2029)
Table 42. Global Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Oral Sustained and Controlled Release Formulations Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Oral Sustained and Controlled Release Formulations Revenue Share by Application (2018-2024)
Table 45. Global Oral Sustained and Controlled Release Formulations Revenue Share by Application (2024-2029)
Table 46. Oral Sustained and Controlled Release Formulations Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Oral Sustained and Controlled Release Formulations Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Oral Sustained and Controlled Release Formulations Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Oral Sustained and Controlled Release Formulations Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Oral Sustained and Controlled Release Formulations Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Oral Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 61. Europe Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 62. Europe Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (K Units)
Table 63. Europe Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Oral Sustained and Controlled Release Formulations Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (K Units)
Table 66. Europe Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (K Units)
Table 67. Europe Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Oral Sustained and Controlled Release Formulations Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Oral Sustained and Controlled Release Formulations Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 73. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 74. China Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 75. China Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (K Units)
Table 76. China Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Oral Sustained and Controlled Release Formulations Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (K Units)
Table 79. China Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (K Units)
Table 80. China Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Oral Sustained and Controlled Release Formulations Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 83. Asia Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (K Units)
Table 84. Asia Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Oral Sustained and Controlled Release Formulations Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (K Units)
Table 87. Asia Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (K Units)
Table 88. Asia Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Oral Sustained and Controlled Release Formulations Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Oral Sustained and Controlled Release Formulations Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Oral Sustained and Controlled Release Formulations Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Oral Sustained and Controlled Release Formulations Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Oral Sustained and Controlled Release Formulations Sales by Region (2018-2024) & (K Units)
Table 94. Asia Oral Sustained and Controlled Release Formulations Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales by Country (2024-2029) & (K Units)
Table 108. Humanwell Healthcare Co.,Ltd. Company Information
Table 109. Humanwell Healthcare Co.,Ltd. Description and Major Businesses
Table 110. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Humanwell Healthcare Co.,Ltd. Recent Developments
Table 113. Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
Table 114. Nanjing Yiheng Pharmaceutical Co., Ltd. Description and Major Businesses
Table 115. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Nanjing Yiheng Pharmaceutical Co., Ltd. Recent Developments
Table 118. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
Table 119. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Major Businesses
Table 120. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments
Table 123. Qilu Pharmaceutical Co Ltd Company Information
Table 124. Qilu Pharmaceutical Co Ltd Description and Major Businesses
Table 125. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Qilu Pharmaceutical Co Ltd Recent Developments
Table 128. Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
Table 129. Shanghai Pharmaceuticals Holding Co.,Ltd. Description and Major Businesses
Table 130. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Shanghai Pharmaceuticals Holding Co.,Ltd. Recent Developments
Table 133. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 134. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Major Businesses
Table 135. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments
Table 138. PKU HealthCare Corp.,Ltd. Company Information
Table 139. PKU HealthCare Corp.,Ltd. Description and Major Businesses
Table 140. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. PKU HealthCare Corp.,Ltd. Recent Developments
Table 143. Overseas Pharmaceuticals, Ltd. Company Information
Table 144. Overseas Pharmaceuticals, Ltd. Description and Major Businesses
Table 145. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Overseas Pharmaceuticals, Ltd. Recent Developments
Table 148. Novast Laboratories (China), LTD. Company Information
Table 149. Novast Laboratories (China), LTD. Description and Major Businesses
Table 150. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Novast Laboratories (China), LTD. Recent Developments
Table 153. Catalent Company Information
Table 154. Catalent Description and Major Businesses
Table 155. Catalent Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Catalent Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Catalent Recent Developments
Table 158. AstraZeneca Plc Company Information
Table 159. AstraZeneca Plc Description and Major Businesses
Table 160. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. AstraZeneca Plc Recent Developments
Table 163. Oakwood Labs Company Information
Table 164. Oakwood Labs Description and Major Businesses
Table 165. Oakwood Labs Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Oakwood Labs Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Oakwood Labs Recent Developments
Table 168. Ascendia Pharma Company Information
Table 169. Ascendia Pharma Description and Major Businesses
Table 170. Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Ascendia Pharma Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Ascendia Pharma Recent Developments
Table 173. Colorcon Company Information
Table 174. Colorcon Description and Major Businesses
Table 175. Colorcon Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Colorcon Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Colorcon Recent Developments
Table 178. Pfizer Inc. Company Information
Table 179. Pfizer Inc. Description and Major Businesses
Table 180. Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Pfizer Inc. Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Pfizer Inc. Recent Developments
Table 183. Mylan Company Information
Table 184. Mylan Description and Major Businesses
Table 185. Mylan Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Mylan Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Mylan Recent Developments
Table 188. Sandoz Company Information
Table 189. Sandoz Description and Major Businesses
Table 190. Sandoz Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Sandoz Oral Sustained and Controlled Release Formulations Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Sandoz Recent Developments
Table 193. Key Raw Materials Lists
Table 194. Raw Materials Key Suppliers Lists
Table 195. Oral Sustained and Controlled Release Formulations Distributors List
Table 196. Oral Sustained and Controlled Release Formulations Customers List
Table 197. Oral Sustained and Controlled Release Formulations Market Trends
Table 198. Oral Sustained and Controlled Release Formulations Market Drivers
Table 199. Oral Sustained and Controlled Release Formulations Market Challenges
Table 200. Oral Sustained and Controlled Release Formulations Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Sustained and Controlled Release Formulations Product Picture
Figure 2. Global Oral Sustained and Controlled Release Formulations Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oral Sustained and Controlled Release Formulations Market Share by Type in 2022 & 2029
Figure 4. Skeleton Type Product Picture
Figure 5. Membrane Controlled Type Product Picture
Figure 6. Osmotic Pump Type Product Picture
Figure 7. Global Oral Sustained and Controlled Release Formulations Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Oral Sustained and Controlled Release Formulations Market Share by Application in 2022 & 2029
Figure 9. Cardiovascular System Drugs
Figure 10. Nervous System Drugs
Figure 11. Digestive System and Metabolism
Figure 12. Other
Figure 13. Oral Sustained and Controlled Release Formulations Report Years Considered
Figure 14. Global Oral Sustained and Controlled Release Formulations Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oral Sustained and Controlled Release Formulations Revenue 2018-2029 (US$ Million)
Figure 16. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2018-2029)
Figure 18. Global Oral Sustained and Controlled Release Formulations Sales 2018-2029 ((K Units)
Figure 19. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Oral Sustained and Controlled Release Formulations Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Oral Sustained and Controlled Release Formulations Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Oral Sustained and Controlled Release Formulations Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Oral Sustained and Controlled Release Formulations Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Oral Sustained and Controlled Release Formulations Sales YoY (2018-2029) & (K Units)
Figure 25. China Oral Sustained and Controlled Release Formulations Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Oral Sustained and Controlled Release Formulations Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Oral Sustained and Controlled Release Formulations Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Oral Sustained and Controlled Release Formulations Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Oral Sustained and Controlled Release Formulations in the World: Market Share by Oral Sustained and Controlled Release Formulations Revenue in 2022
Figure 32. Global Oral Sustained and Controlled Release Formulations Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
Figure 34. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
Figure 35. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
Figure 36. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Oral Sustained and Controlled Release Formulations Revenue Share by Country (2018-2029)
Figure 42. US & Canada Oral Sustained and Controlled Release Formulations Sales Share by Country (2018-2029)
Figure 43. U.S. Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
Figure 46. Europe Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
Figure 47. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
Figure 48. Europe Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2029)
Figure 49. Europe Oral Sustained and Controlled Release Formulations Revenue Share by Country (2018-2029)
Figure 50. Europe Oral Sustained and Controlled Release Formulations Sales Share by Country (2018-2029)
Figure 51. Germany Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 52. France Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 56. China Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
Figure 57. China Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
Figure 58. China Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
Figure 59. China Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2029)
Figure 60. Asia Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
Figure 61. Asia Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
Figure 62. Asia Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
Figure 63. Asia Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2018-2029)
Figure 64. Asia Oral Sustained and Controlled Release Formulations Revenue Share by Region (2018-2029)
Figure 65. Asia Oral Sustained and Controlled Release Formulations Sales Share by Region (2018-2029)
Figure 66. Japan Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 70. India Oral Sustained and Controlled Release Formulations Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Oral Sustained and Controlled Release Formulations Revenue Market Share by Application

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries